Freire de Medeiros Camila Maroni Marques, Arantes Eder Pinheiro, Tajra Rafael Dib de Paulo, Santiago Hendrio Reginaldo, Carvalho André Ferrer, Libório Alexandre Braga
a Medical Sciences Post-graduate Program, Department of Clinical Medicine , Universidade Federal do Ceará , Fortaleza , Brazil.
b Medical Sciences Post-graduate Program , Universidade de Fortaleza - UNIFOR , Fortaleza , Brazil.
Psychol Health Med. 2017 Jun;22(5):570-577. doi: 10.1080/13548506.2016.1191658. Epub 2016 Jun 1.
Resilience and religiosity have received attention as an important process in the experience and management of chronic comorbidities; however, there is no study evaluating resilience in hemodialysis patients and its association with other psychological dimensions or with treatment adherence. This observational prospective study assessed resilience (25 item Wagnild and Young Resilience Scale), religiosity under three dimensions (organizational, non-organizational and intrinsic) using DUREL scale, depressive symptoms (Patient Health Questionnaire-9) and health-related quality of life (Short Form-36 questionnaire). The main outcomes were medication adherence using the Morisky Medication Adherence Scale-8 (MMAR-8) and the missing/shortened dialysis sessions in the following six months. Of 208 patients approached, 202 (97.1%) agreed to participate. One hundred twenty-three patients (60.9%) were males and mean age was 52.8 ± 14.8 years-old. The median time on hemodialysis was 36 months (IQR, 12, 84). 82 (40.6%) patients obtained a MMAS-8 score <6 and were considered as having 'poor adherence'. Overall, the mean score of medication adherence was low (5.7 ± 2.1). About adherence to hemodialysis sessions, patients missed a total of 234 (1.6%) hemodialysis sessions. Forty-eight patients (23.7%) missed an average of at least three sessions in six months. Regarding adherence to medication, there was no association in the uni- or multivariate analysis between religiosity dimensions and MMAS-8 score. After adjustment, resilience was positively associated with MMAS-8 score (standardized β coefficient .239, p = .016). Organized and intrinsic religiosity were associated with adherence to dialysis sessions (standardized β coefficient .258, p = .004 and .231, p = .026, respectively). Interestingly, opposite to medication adherence, more resilient patients were associated with less adherence to hemodialysis sessions (standardized β coefficient -.296, p = .001). Religiosity was associated with dialysis adherence but not with medication adherence. Resilience was associated with higher medication adherence but lower adherence to dialysis sessions.
复原力和宗教信仰作为慢性合并症体验和管理中的一个重要过程受到了关注;然而,尚无研究评估血液透析患者的复原力及其与其他心理维度或治疗依从性的关联。这项观察性前瞻性研究使用25项Wagnild和Young复原力量表评估复原力,使用DUREL量表从组织性、非组织性和内在性三个维度评估宗教信仰,使用患者健康问卷-9评估抑郁症状,使用简短健康调查问卷-36评估健康相关生活质量。主要结局指标是使用Morisky药物依从性量表-8(MMAR-8)评估的药物依从性以及接下来六个月内错过/缩短的透析疗程。在208名被邀请的患者中,202名(97.1%)同意参与。123名患者(60.9%)为男性,平均年龄为52.8±14.8岁。血液透析的中位时间为36个月(四分位间距,12, 84)。82名(40.6%)患者的MMAS-8评分<6,被认为“依从性差”。总体而言,药物依从性的平均得分较低(5.7±2.1)。关于透析疗程的依从性,患者总共错过234次(1.6%)透析疗程。48名患者(23.7%)在六个月内平均至少错过三次疗程。关于药物依从性,在单因素或多因素分析中,宗教信仰维度与MMAS-8评分之间均无关联。调整后,复原力与MMAS-8评分呈正相关(标准化β系数为0.239,p = 0.016)。有组织的宗教信仰和内在宗教信仰与透析疗程的依从性相关(标准化β系数分别为0.258,p = 0.004和0.231,p = 0.026)。有趣的是,与药物依从性相反,复原力更强的患者与透析疗程的依从性更低相关(标准化β系数为-0.296,p = 0.001)。宗教信仰与透析依从性相关,但与药物依从性无关。复原力与更高的药物依从性相关,但与透析疗程的依从性较低相关。